NeoGenomics
263 hedge funds and large institutions have $2.02B invested in NeoGenomics in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 90 reducing their positions, and 49 closing their positions.
368% more call options, than puts
Call options by funds: $22.4M | Put options by funds: $4.78M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
2.09% more ownership
Funds ownership: 98.67% → 100.76% (+2.1%)
1% less capital invested
Capital invested by funds: $2.04B → $2.02B (-$13.8M)
8% less funds holding
Funds holding: 287 → 263 (-24)
14% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 90
39% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.9M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$17M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$14.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.1M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$9.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$18.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$12.6M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$11.9M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$9.64M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$3.85M |
NEO Hedge Fund Activity: Q1 2024 in Review
263 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2024, worth a combined $2.02B — down 0.68% from $2.04B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of NEO and 30 opened new positions — a net loss of 19 holders — while 90 trimmed existing stakes and 77 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $33.9M. The largest seller was Invesco, cutting an estimated $18.2M.
- 263 institutional investors held NeoGenomics (NEO) as of Q1 2024, down from 287 in Q4 2023.
- Funds reported $2.02B of NeoGenomics stock for Q1 2024, down 0.68% quarter-over-quarter.
- 30 funds opened new NeoGenomics positions in Q1 2024 and 49 closed out, a net change of -19 holders.
- The largest NeoGenomics buyer in Q1 2024 was Point72 Asset Management, an estimated $33.9M added.
- The largest NeoGenomics seller in Q1 2024 was Invesco, an estimated $18.2M sold.
Based on aggregated 13F filings for Q1 2024.